Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2007
12/21/2007CA2654791A1 A method of reducing amyloid-beta peptide levels using a bisdioxopiperazine
12/21/2007CA2654722A1 Thiadiazole compounds and methods of use thereof
12/21/2007CA2654557A1 Combination preparations comprising bifeprunox and l-dopa
12/21/2007CA2654405A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007CA2654403A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2653686A1 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
12/21/2007CA2653682A1 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
12/21/2007CA2653679A1 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/21/2007CA2653030A1 Ache-nmda combination wafer
12/21/2007CA2652476A1 Combination antidepressants wafer
12/21/2007CA2651684A1 Peptide compounds for treating refractory status epilepticus
12/21/2007CA2651679A1 Pharmaceutical composition with synergistic anticonvulsant effect
12/20/2007US20070293584 Modified release formulations of a bupropion salt
12/20/2007US20070293583 Use of low-dose ladostigil for neuroprotection
12/20/2007US20070293576 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
12/20/2007US20070293573 Glu2 receptor modulators
12/20/2007US20070293572 Anti-Fatigue Composition
12/20/2007US20070293570 Pharmaceutical uses for alpha2delta ligands
12/20/2007US20070293567 Substituted biphenyl carboxylic acids and derivatives thereof
12/20/2007US20070293563 Novel Agents for Preventing and Treating Disorders Connected to Impaired Neurotransmission
12/20/2007US20070293560 Compounds and compositions
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293553 Diphenylurea Derivatives Useful As Potassium Channel Activators
12/20/2007US20070293545 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
12/20/2007US20070293542 Selective Cox-2 Inhibitors
12/20/2007US20070293541 CB1 cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
12/20/2007US20070293539 Methods for the treatment of synucleinopathies
12/20/2007US20070293538 Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
12/20/2007US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/20/2007US20070293515 1,3-Disubstituted Heteroaryl Nmda/Nr2b Antagonists
12/20/2007US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound
12/20/2007US20070293511 Crf Receptor Antagonists and Methods
12/20/2007US20070293508 Crf Receptor Antagonists and Methods Relating Thereto
12/20/2007US20070293502 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293497 2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070293492 Quinoline Tachykinin Receptor Antagonists
12/20/2007US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes
12/20/2007US20070293479 Olanzapine pharmaceutical composition
12/20/2007US20070293477 Novel Compounds
12/20/2007US20070293470 Carboxamide Spirolactam Cgrp Receptor Antagonists
12/20/2007US20070293464 Substituted Pyrimidine Compositions and Methods of Use
12/20/2007US20070293450 Identification of ses-3 and the uses of same
12/20/2007US20070293431 Method for improving neurotransmission failure using a novel agent
12/20/2007US20070293422 Beta-Amyloid Inhibitors and Use Thereof
12/20/2007US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007US20070292532 Vanadium Compounds as Inhibitors of Phosphatases
12/20/2007US20070292524 Delivery vehicle containing nanoparticles
12/20/2007US20070292515 Solid dosage form containing a taste masked active agent
12/20/2007US20070292511 Duloxetine hydrochloride delayed release formulations
12/20/2007US20070292500 Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate
12/20/2007US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/20/2007US20070292422 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant
12/20/2007US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances
12/20/2007US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders
12/20/2007US20070292403 Methods of treating a neurological disorder with creatine monohydrate
12/20/2007US20070292391 formulations of interferon-beta comprising a buffer, an amino acid and an antioxidant; comprising interferon-beta 1a, lysine, methionine, poloxomer 188 and an aqueous acetate buffer
12/20/2007DE102006027795A1 Raucherentwöhnungs-Kombinationswafer Smoking cessation combination wafer
12/20/2007DE102006027793A1 Opioid-Kombinations-Wafer Opioid combination wafer
12/20/2007DE102006027792A1 Antidepressiva-Kombinations-Wafer Antidepressants Combination wafer
12/20/2007DE102006027791A1 AchE-NMDA-Kombinationswafer AchE NMDA combination wafer
12/19/2007EP1867717A1 Method of ameliorating symptom caused by mood disturbance
12/19/2007EP1867642A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia
12/19/2007EP1867641A1 Preventive or remedy for depression or anxiety neurosis
12/19/2007EP1867636A1 Pyridylmethylsulfone derivative
12/19/2007EP1867343A2 Novel compounds
12/19/2007EP1867342A1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
12/19/2007EP1867333A1 Pharmaceutical composition comprising condensed indole compound
12/19/2007EP1867329A2 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds
12/19/2007EP1867327A1 Astaxanthin and esters thereof for protecting neurocytes and treating Parkinson's disease
12/19/2007EP1866314A1 Novel diazabicyclic aryl derivatives and their medical use
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866304A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/19/2007EP1866300A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
12/19/2007EP1866275A1 Crystalline forms of pregabalin
12/19/2007EP1866034A1 Substituted 1,2-ethylendiamines, medicaments comprising said compound; their use and their method of manufacture
12/19/2007EP1865962A2 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
12/19/2007EP1865955A2 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
12/19/2007EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer
12/19/2007EP1865951A1 Method for preventing cardiovascular diseases
12/19/2007EP1865950A1 Compounds useful as modulators of the proteasome activity
12/19/2007EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007EP1865779A2 Compositions and methods for ameliorating cachexia
12/19/2007EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders
12/19/2007EP1682124B1 Pharmaceutical compositions based on idazoxan salt or one of its polymorphs
12/19/2007EP1628648B1 Deramciclane-fumarate tablets
12/19/2007EP1601358B1 2,5-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1487285B1 Alertness bar
12/19/2007EP1470122B1 Rho-kinase inhibitors
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists
1 ... 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 ... 1833